Glenmede Trust CO Na Axonics, Inc. Transaction History

Glenmede Trust CO Na

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$52.6 - $67.34 $135,708 - $173,737	-2,580 Reduced 26.74%	7,070 $385,000
Q4 2022 Feb 14, 2023	SELL	$59.56 - $76.6 $18,642 - $23,975	-313 Reduced 3.14%	9,650 $603,000
Q3 2022 Nov 16, 2022	BUY	$57.96 - $78.12 $144,726 - $195,065	2,497 Added 33.44%	9,963 $701,000
Q2 2022 Aug 15, 2022	BUY	$39.5 - $64.42 $294,907 - $480,959	7,466 New	7,466 $423,000
Q1 2022 May 16, 2022	SELL	$43.74 - $62.76 $820,956 - $1.18 Million	-18,769 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$50.01 - $73.35 $938,637 - $1.38 Million	18,769 New	18,769 $1.05 Million

234

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.